Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Genoveffa Franchini

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2011
Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNAShari N Gordon, Rhonda C Kines, Galyna Kutsyna, et al.
Journal of Virology|July 19, 2019
Essential Role of Human T Cell Leukemia Virus Type 1 <i>orf-I</i> in Lethal Proliferation of CD4<sup>+</sup> Cells in Humanized MiceVeronica Galli, Christopher C Nixon, Natasa Strbo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Subunit recombinant vaccine protects against monkeypoxJean-Michel Heraud, Yvette Edghill-Smith, Victor Ayala, et al.
Journal of Virology|January 18, 2013
Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposureMonica Vaccari, Brandon F Keele, Steven E Bosinger, et al.
Nature Immunology|September 24, 2021
The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccinationJeffrey Alan Tomalka, Adam Nicolas Pelletier, Slim Fourati, et al.
Journal of Virology|November 24, 2012
Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trialPoonam Pegu, Monica Vaccari, Shari Gordon, et al.
Journal of Virology|January 15, 2010
Preexisting infection with human T-cell lymphotropic virus type 2 neither exacerbates nor attenuates simian immunodeficiency virus SIVmac251 infection in macaquesShari N Gordon, Anna R Weissman, Valentina Cecchinato, et al.
Plos Pathogens|April 4, 2022
NK cells and monocytes modulate primary HTLV-1 infectionRamona Moles, Sarkis Sarkis, Veronica Galli, et al.
The Journal of Infectious Diseases|October 11, 2003
Modeling a safer smallpox vaccination regimen, for human immunodeficiency virus type 1-infected patients, in immunocompromised macaquesYvette Edghill-Smith, David Venzon, Tatiana Karpova, et al.
The Journal of Clinical Investigation|February 19, 2019
Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody responseYongjun Sui, George K Lewis, Yichuan Wang, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2011
Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNAShari N Gordon, Rhonda C Kines, Galyna Kutsyna, et al.
Journal of Virology|July 19, 2019
Essential Role of Human T Cell Leukemia Virus Type 1 <i>orf-I</i> in Lethal Proliferation of CD4<sup>+</sup> Cells in Humanized MiceVeronica Galli, Christopher C Nixon, Natasa Strbo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Subunit recombinant vaccine protects against monkeypoxJean-Michel Heraud, Yvette Edghill-Smith, Victor Ayala, et al.
Journal of Virology|January 18, 2013
Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposureMonica Vaccari, Brandon F Keele, Steven E Bosinger, et al.
Nature Immunology|September 24, 2021
The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccinationJeffrey Alan Tomalka, Adam Nicolas Pelletier, Slim Fourati, et al.
Journal of Virology|November 24, 2012
Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trialPoonam Pegu, Monica Vaccari, Shari Gordon, et al.
Journal of Virology|January 15, 2010
Preexisting infection with human T-cell lymphotropic virus type 2 neither exacerbates nor attenuates simian immunodeficiency virus SIVmac251 infection in macaquesShari N Gordon, Anna R Weissman, Valentina Cecchinato, et al.
Plos Pathogens|April 4, 2022
NK cells and monocytes modulate primary HTLV-1 infectionRamona Moles, Sarkis Sarkis, Veronica Galli, et al.
The Journal of Infectious Diseases|October 11, 2003
Modeling a safer smallpox vaccination regimen, for human immunodeficiency virus type 1-infected patients, in immunocompromised macaquesYvette Edghill-Smith, David Venzon, Tatiana Karpova, et al.
The Journal of Clinical Investigation|February 19, 2019
Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody responseYongjun Sui, George K Lewis, Yichuan Wang, et al.
Pageof 17